메뉴 건너뛰기




Volumn 16, Issue 3, 2011, Pages 225-228

A New Modified Concomitant Therapy for Helicobacter pylori Eradication in Turkey

Author keywords

Eradication; Helicobacter pylori; Metronidazole; Resistance

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE;

EID: 79956104004     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2011.00823.x     Document Type: Article
Times cited : (29)

References (19)
  • 1
    • 34247844165 scopus 로고    scopus 로고
    • Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
    • Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81.
    • (2007) Gut , vol.56 , pp. 772-781
    • Malfertheiner, P.1    Megraud, F.2    O'Morain, C.3
  • 2
    • 0031932458 scopus 로고    scopus 로고
    • Report of the 1997 Asia Pacific Consensus on the management of Helicobacter pylori infection
    • Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998;13:1-12.
    • (1998) J Gastroenterol Hepatol , vol.13 , pp. 1-12
    • Lam, S.K.1    Talley, N.J.2
  • 3
    • 23844454901 scopus 로고    scopus 로고
    • Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents--an evidence-based evaluation
    • Bourke B, Ceponis P, Chiba N, et al. Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents--an evidence-based evaluation. Can J Gastroenterol 2005;19:399-408.
    • (2005) Can J Gastroenterol , vol.19 , pp. 399-408
    • Bourke, B.1    Ceponis, P.2    Chiba, N.3
  • 4
    • 0029147865 scopus 로고
    • The treatment of Helicobacter pylori infection in the management of peptic ulcer disease
    • Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995;333:984-91.
    • (1995) N Engl J Med , vol.333 , pp. 984-991
    • Walsh, J.H.1    Peterson, W.L.2
  • 5
    • 0030877226 scopus 로고    scopus 로고
    • Current european concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report
    • The European Helicobacter Pylori Study Group
    • The European Helicobacter Pylori Study Group. Current european concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997;41:8-13.
    • (1997) Gut , vol.41 , pp. 8-13
  • 6
    • 0033629462 scopus 로고    scopus 로고
    • Regular review: treatment of Helicobacter pylori infection
    • De Boer WA, Tytgat GN. Regular review: treatment of Helicobacter pylori infection. Br Med J 2000;320:31-4.
    • (2000) Br Med J , vol.320 , pp. 31-34
    • De Boer, W.A.1    Tytgat, G.N.2
  • 7
    • 0034170933 scopus 로고    scopus 로고
    • Effectiveness of omeprazole, clarithromycin and amoxicillin therapy to eradicate Helicobacter pylori in patients with active peptic ulcer. Preliminary results GENPY study
    • Baqos F, Madridejos R, Cabezas C, Burrull M, Lafuente C, Morrera R. Effectiveness of omeprazole, clarithromycin and amoxicillin therapy to eradicate Helicobacter pylori in patients with active peptic ulcer. Preliminary results GENPY study. Med Clin (Barc) 2000;114:441-3.
    • (2000) Med Clin (Barc) , vol.114 , pp. 441-443
    • Baqos, F.1    Madridejos, R.2    Cabezas, C.3    Burrull, M.4    Lafuente, C.5    Morrera, R.6
  • 8
    • 0036617893 scopus 로고    scopus 로고
    • Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy. A randomized study
    • Palmas F, Pellicano R, Massimetti E, Berruti M, Fagoone S, Rizzetto M. Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy. A randomized study. Panminerva Med 2002;44:145-7.
    • (2002) Panminerva Med , vol.44 , pp. 145-147
    • Palmas, F.1    Pellicano, R.2    Massimetti, E.3    Berruti, M.4    Fagoone, S.5    Rizzetto, M.6
  • 9
    • 33845995030 scopus 로고    scopus 로고
    • Comparison of 7 and 14 days lansoprazole, amoxicillin, clarithromycin therapies to eradicate Hp in Hp positive dyspeptic patients in Turkish population
    • Uygun A, Yeşilova Z, Ateş Y, et al. Comparison of 7 and 14 days lansoprazole, amoxicillin, clarithromycin therapies to eradicate Hp in Hp positive dyspeptic patients in Turkish population. Turk J Gastroenterol 2004;1(Suppl. 1):138.
    • (2004) Turk J Gastroenterol , vol.1 , Issue.SUPPL. 1 , pp. 138
    • Uygun, A.1    Yeşilova, Z.2    Ateş, Y.3
  • 10
    • 33144469642 scopus 로고    scopus 로고
    • The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycin-resistant and sensitive cases
    • Aydin A, Faik G, Onder F, et al. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycin-resistant and sensitive cases. Turkish J Gastroenterol 2005;16:203-206
    • (2005) Turkish J Gastroenterol , vol.16 , pp. 203-206
    • Aydin, A.1    Faik, G.2    Onder, F.3
  • 11
    • 33845975682 scopus 로고    scopus 로고
    • Eradication of Hp with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years
    • Kadayifci A, Buyukhatipoglu H, Cemil Savas M, Simsek I. Eradication of Hp with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years. Clin Ther 2006;28:1960-6.
    • (2006) Clin Ther , vol.28 , pp. 1960-1966
    • Kadayifci, A.1    Buyukhatipoglu, H.2    Cemil Savas, M.3    Simsek, I.4
  • 12
    • 62149086210 scopus 로고    scopus 로고
    • Meta-analysis: four drug, three antibiotics, non-bismuth containing 'concomitant therapy' versus triple therapy for Helicobacter pylori eradication
    • Essa AS, Kramer JR, Graham DY, Treiber G. Meta-analysis: four drug, three antibiotics, non-bismuth containing 'concomitant therapy' versus triple therapy for Helicobacter pylori eradication. Helicobacter 2009;1:109-18.
    • (2009) Helicobacter , vol.1 , pp. 109-118
    • Essa, A.S.1    Kramer, J.R.2    Graham, D.Y.3    Treiber, G.4
  • 13
    • 15544380448 scopus 로고    scopus 로고
    • Staging and grading of chronic gastritis
    • Rugge M, Genta RM. Staging and grading of chronic gastritis. Hum Pathol 2005;36:228-33.
    • (2005) Hum Pathol , vol.36 , pp. 228-233
    • Rugge, M.1    Genta, R.M.2
  • 15
    • 12144289669 scopus 로고    scopus 로고
    • Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey
    • Gumurdulu Y, Serin E, Ozer B, et al. Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. World J Gastroenterol 2004;10:668-71.
    • (2004) World J Gastroenterol , vol.10 , pp. 668-671
    • Gumurdulu, Y.1    Serin, E.2    Ozer, B.3
  • 16
    • 34447298402 scopus 로고    scopus 로고
    • Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori
    • Fischbach L, Evans EL. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment Pharmacol Ther 2007;26:343-57.
    • (2007) Aliment Pharmacol Ther , vol.26 , pp. 343-357
    • Fischbach, L.1    Evans, E.L.2
  • 17
    • 77954704743 scopus 로고    scopus 로고
    • Helicobacter pylori treatment in the era of increasing antibiotic resistance
    • Epub 2010 Jun 4. Review.
    • Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010;59:1143-53. Epub 2010 Jun 4. Review.
    • (2010) Gut , vol.59 , pp. 1143-1153
    • Graham, D.Y.1    Fischbach, L.2
  • 18
    • 85047688500 scopus 로고    scopus 로고
    • The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori
    • Uygun A, Kadayifci A, Safali M, Ilgan S, Bagci S. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori. J Dig Dis 2007;8:211-5.
    • (2007) J Dig Dis , vol.8 , pp. 211-215
    • Uygun, A.1    Kadayifci, A.2    Safali, M.3    Ilgan, S.4    Bagci, S.5
  • 19
    • 78049503288 scopus 로고    scopus 로고
    • Empirical levofloxacin-containing versus clarithromycin containing sequential therapy for Helicobacter pylori eradication: a randomised trial
    • Romano M, Cuomo A, Gravina AG, et al. Empirical levofloxacin-containing versus clarithromycin containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Gut 2010;59:1465-70.
    • (2010) Gut , vol.59 , pp. 1465-1470
    • Romano, M.1    Cuomo, A.2    Gravina, A.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.